Related content

Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France

By Livartowski A.   Boucher J.   Detournay B.   Reinert P.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 495-500

Elsevier

Access to resources Recommend Favorite

Differing serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and Caucasian infants - implications for disease epidemiology

By Guthridge S.   McIntyre P.   Isaacs D.   Hanlon M.   Patel M.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2584-2591

Elsevier

Access to resources Recommend Favorite

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age

By Aristegui J.   Dal-Re R.   Garrote E.   Gonzalez A.   Arrate J.-P.   Perez A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1976-1981

Elsevier

Access to resources Recommend Favorite

High rates of recombination in otitis media isolates of non-typeable Haemophilus influenzae

By Cody A.J.   Field D.   Feil E.J.   Stringer S.   Deadman M.E.   Tsolaki A.G.   Gratz B.   Bouchet V.   Goldstein R.   Hood D.W.   Moxon E.R.  

Infection, Genetics and Evolution, Vol. 3, Iss. 1, 2003-05 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite

Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine

By Hviid A.   Melbye M.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 378-382

Elsevier

Access to resources Recommend Favorite